Scade il 6 settembre 2018 la seconda possibilità di presentare proposte di progetto per gli inviti pubblicati nell'ambito del programma Horizon 2020 relativi all'iniziativa tecnologica congiunta sui medicinali innovativi.
Tra i temi di ricerca aperta del presente invito a presentare proposte figurano: le malattie tumorali, cardiovascolari, respiratorie e neurodegenerative, il diabete, le malattie rare, la sicurezza dei farmaci, la piattaforma europea per le cellule staminali pluripotenti, ecc.
- Invito a presentare proposte "Societal challenges" IMI2 - 2017-13-01: Assessment of the uniqueness of diabetic cardiomyopathy relative to other forms of heart failure using unbiased pheno-mapping approaches
- Invito a presentare proposte "Societal challenges" IMI2-2017-13-02: Genome-Environment Interactions in Inflammatory Skin Disease
- Invito a presentare proposte "Societal challenges" IMI2-2017-13-03: The value of diagnostics to combat antimicrobial resistance by optimising antibiotic use
- Invito a presentare proposte "Societal challenges" IMI2-2017-13-04: Mitochondrial Dysfunction in Neurodegeneration
- Invito a presentare proposte "Societal challenges" IMI2-2017-13-05: Support and coordination action for the projects of the Neurodegeneration area of the Innovative Medicines Initiative
- Invito a presentare proposte "Societal challenges" IMI2-2017-13-06: A sustainable European induced pluripotent stem cell platform
- Invito a presentare proposte "Societal challenges" IMI2-2017-13-07: Linking digital assessment of mobility to clinical endpoints to support regulatory acceptance and clinical practice
- Invito a presentare proposte "Societal challenges" IMI2-2017-13-08: Human Tumour Microenvironment Immunoprofiling
- Invito a presentare proposte "Societal challenges" IMI2-2017-13-09: ConcePTION – Continuum of Evidence from Pregnancy Exposures, Reproductive Toxicology and Breastfeeding to Improve Outcomes
- Invito a presentare proposte "Societal challenges" IMI2-2017-13-10: Improving the preclinical prediction of adverse effects of pharmaceuticals on the nervous system
- Invito a presentare proposte "Societal challenges" IMI2-2017-13-11: Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease
- Invito a presentare proposte "Societal challenges" IMI2-2017-13-12: Pilot programme on a Clinical Compound Bank for Repurposing: Cardiovascular diseases and diabetes
- Invito a presentare proposte "Societal challenges" IMI2-2017-13-13: Pilot programme on a Clinical Compound Bank for Repurposing: Respiratory diseases
- Invito a presentare proposte "Societal challenges" IMI2-2017-13-14: Pilot programme on a Clinical Compound Bank for Repurposing: Neurodegenerative diseases
- Invito a presentare proposte "Societal challenges" IMI2-2017-13-15: Pilot programme on a Clinical Compound Bank for Repurposing: Rare/orphan diseases
Tag:
Data :
12 Dicembre, 2017
Data fine:
6 Settembre, 2018
Progetto di riferimento: